Literature DB >> 15197705

Quality of life in Polish patients with long-lasting Parkinson's disease.

Marcin Zach1, Andrzej Friedman, Jarosław Sławek, Mirosława Derejko.   

Abstract

The objective of this study was to evaluate possible relationships between quality of life (QoL) of Polish patients with long-lasting Parkinson's disease and various demographic and clinical factors. The study comprised 141 patients of Movement Disorders outpatient clinics in Warsaw and Gdansk with at least 5 years of the disease duration. Mean age of patients was 68.09 +/- 8.51 years, mean duration of disease was 11.87 +/- 5.14 years. To assess the quality of life, the Parkinson's Disease Questionnaire (PDQ-39) was used. Additional questions concerned duration of disease, initial and current treatment and expenses associated with therapy. Self-perceived symptoms of depression were in our study the most important factor determining QoL. Duration of the disease and expenses related to the treatment also have a significant impact on the QoL. Patient's age and presence of dyskinesia seem to be irrelevant to the quality of life. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197705     DOI: 10.1002/mds.10698

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Health-related quality of life of australians with Parkinson disease: a comparison with international studies.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Meg E Morris
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

Review 2.  Risk Factors for Malnutrition in Older Adults: A Systematic Review of the Literature Based on Longitudinal Data.

Authors:  Nádia Cristina Fávaro-Moreira; Stefanie Krausch-Hofmann; Christophe Matthys; Carine Vereecken; Erika Vanhauwaert; Anja Declercq; Geertruida Elsiena Bekkering; Joke Duyck
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

Review 3.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.

Authors:  Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

5.  Treatment of Parkinson's disease: a survey of patients and neurologists.

Authors:  Matthias Fargel; Bernd Grobe; Eberhard Oesterle; Claudia Hastedt; Markus Rupp
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).

Authors:  Morgana Moretti; Vivian Binder Neis; Filipe Carvalho Matheus; Mauricio Peña Cunha; Priscila Batista Rosa; Camille Mertins Ribeiro; Ana Lúcia S Rodrigues; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2015-07-09       Impact factor: 3.911

7.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

8.  Improved nutritional status is related to improved quality of life in Parkinson's disease.

Authors:  Jamie M Sheard; Susan Ash; George D Mellick; Peter A Silburn; Graham K Kerr
Journal:  BMC Neurol       Date:  2014-11-18       Impact factor: 2.474

Review 9.  Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.

Authors:  Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 10.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.